KYNB
Kyntra Bio, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$8.55
+0.71%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- 1.68x
- Debt / assets
- 0.00x
- Debt / EBITDA
- 0.00x
- Net debt / EBITDA
- 0.54x
Liquidity & coverage
- Current ratio
- 2.69x
- Quick ratio
- 2.59x
- Cash ratio
- 2.53x
- Interest coverage
- -5.47x
- EBITDA / interest
- -10.12x
- Working capital
- $60.8M
Cash & dividend
- FCF / debt
- —
- Cash flow / debt
- —
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026